SC 13G/A: BRIGHT MINDS BIOSCIENCES INC.

AI Summary

SC 13G/A filing by BRIGHT MINDS BIOSCIENCES INC..

Risk Assessment

Risk Level: low

FAQ

Filing Documents

• tm2426599d1_sc13ga.htm (SC 13G/A) — 114KB
• tm2426599d1_ex99-1.htm (EX-99.1) — 7KB
• 0001104659-24-110554.txt ( ) — 122KB

(a) Name

Item 1(a) Name of Issuer Bright Minds Biosciences Inc.

(b)

Item 1(b) Address of Issuer’s Principal Executive Offices 19 Vestry Street, New York, NY 10013 Item 2(a) Name of Person Filing This Schedule 13G is being jointly filed by PFM Health Sciences, LP (“PFM”), PFM Health Sciences GP, LLC (“PFM-GP”), Partner Asset Management, LLC (“PAM”), and Brian D. Grossman (“Grossman” and, collectively with PFM, PFM-GP and PAM, the “Reporting Persons”) with respect to the common stock of the above-named issuer owned by PFM Healthcare Master Fund, L.P., a Cayman Islands limited partnership (“HCM”). PFM is the investment advisor for HCM. PAM is the general partner of HCM. PFM-GP is the general partner of PFM and the manager of PAM. Grossman is the sole member of PFM-GP. The filing of this statement shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any securities covered by the statement other than the securities actually owned by such person (if any). Item 2(b) Address or Principal Business Office or, if none, Residence The address of the principal business office of each of the Reporting Persons is c/o PFM Health Sciences, LP, 475 Sansome Street, Suite 1720, San Francisco, California 94111. Item 2(c) Citizenship PFM is organized as a limited partnership under the laws of the State of Delaware. Each of PFM-GP, HCG-GP and PAM is organized as a limited liability company under the laws of the State of Delaware. Grossman is a U.S. citizen. Item 2(d) Title of Class of Securities Common Shares, Without Par Value Item 2(e) CUSIP Number 10919W405 CUSIP No. 10919W405 13G Page 7 of 11 Pages

If

Item 3 If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under Section 15 of the Exchange Act; (b) Bank as defined in Section 3(a)(6) of the Exchange Act; (c) Insurance company as defined in Section 3(a)(19) of the Exchange Act; (d) Investment company registered under Section 8 of the Investment Company Act; (e) An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J); (k) Group, in accordance with Rule 13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: ____________. CUSIP No. 10919W405 13G Page 8 of 11 Pages Item 4 A. PFM Health Sciences, LP, PFM Health Sciences GP, LLC, and Partner Asset Management, LLC (a) PFM, PFM-GP and PAM may be deemed to beneficially own 0 shares of Common Shares. (b) The number of shares PFM, PFM-GP and PAM may be deemed to beneficially own constitutes approximately 0.0% of the Common Shares outstanding. (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 0 (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 0 (iv) shared power to dispose or to direct the disposition of: 0 B. Brian D. Grossman (a) Grossman may be deemed to beneficially own 0 shares of Common Shares. (b) The number of shares Grossman may b

Ownership

Item 6 Ownership of More than Five Percent on Behalf of Another Person Not Applicable

Identification

Item 7 Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company See Item 2 above CUSIP No. 10919W405 13G Page 9 of 11 Pages

Identification

Item 8 Identification and Classification of Members of the Group Not Applicable

Notice

Item 9 Notice of Dissolution of Group Not Applicable Item 10 Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. CUSIP No. 10919W405 13G Page 10 of 11 Pages After reasonable inquiry and to the best of its knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Dated this 22 nd day of October, 2024. PFM Health Sciences, LP PFM Health Sciences GP, LLC By: PFM Health Sciences GP, LLC, By: /s/ Darren Mooney its general partner Darren Mooney, Authorized Signatory By: /s/ Darren Mooney Darren Mooney, Authorized Signatory PARTNER Asset MANAGEMENT, LLC BRIAN D. GROSSMAN By: PFM Health Sciences GP, LLC, By: /s/ Darren Mooney its manager Darren Mooney, attorney-in-fact * By: /s/ Darren Mooney Darren Mooney, Authorized Signatory * Darren Mooney is signing on behalf of Brian Grossman as attorney-in-fact pursuant to a power of attorney dated February 1, 2024, and incorporated by reference herein. The power of attorney was filed as an attachment to a filing by certain of the Reporting Persons on Schedule 13G/A for Praxis Precision Medicines, Inc. on February 14, 2024.

View Full Filing

View this SC 13G/A filing on SEC EDGAR